WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014180182) [1,2,4] TRIAZOL [4,3-A] PYRIDINE DERIVATE, PREPARATION METHOD THEREFOR OR MEDICAL APPLICATION THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/180182    International Application No.:    PCT/CN2014/072825
Publication Date: 13.11.2014 International Filing Date: 04.03.2014
IPC:
C07D 487/04 (2006.01), C07D 471/02 (2006.01), A61K 31/503 (2006.01), A61K 31/4745 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01)
Applicants: JIANGSU HANSOH PHARMACEUTICAL CO., LTD. [CN/CN]; The 10th Industrial Sub-Zone of Development Zone Lianyungang, Jiangsu 222047 (CN)
Inventors: ZHAO, Zhiming; (CN).
WANG, Haiyang; (CN).
WU, Chenchen; (CN).
QI, Qingqing; (CN)
Agent: GE CHENG & CO., LTD.; Level 19, Tower E3, The Towers, Oriental Plaza No.1, East Chang An Avenue, Dongcheng District Beijing 100738 (CN)
Priority Data:
201310173581.4 10.05.2013 CN
Title (EN) [1,2,4] TRIAZOL [4,3-A] PYRIDINE DERIVATE, PREPARATION METHOD THEREFOR OR MEDICAL APPLICATION THEREOF
(FR) DÉRIVÉ DE [1,2,4]-TRIAZOLE-[4,3-A]-PYRIDINE, PROCÉDÉ DE PRÉPARATION CORRESPONDANT OU APPLICATION MÉDICALE CORRESPONDANTE
(ZH) [1,2,4]三唑并[4,3-a]吡啶类衍生物,其制备方法或其在医药上的应用
Abstract: front page image
(EN)Provided are a [1,2,4] triazol [4,3-a] pyridine derivate shown in the general formula (I), a preparation method therefor, and a pharmaceutical composition containing the derivate, wherein the pharmaceutical composition is used as a therapeutic agent, and especially, used as a c-Met inhibitor and an immunosuppressant; and each substituent in the general formula (I) is same as that defined in the specification.
(FR)L'invention concerne un dérivé de [1,2,4]-triazole-[4,3-A]-pyridine représenté dans la formule générale (I), un procédé de préparation correspondant et une composition pharmaceutique contenant le dérivé, la composition pharmaceutique étant utilisée comme agent thérapeutique et, plus particulièrement, utilisée comme inhibiteur de c-Met et immunosuppresseur ; et chaque substituant dans la formule générale (I) étant identique à la définition dans la description.
(ZH)提供一种如通式(I)所示的[1,2,4]三唑并[4,3-a]吡啶类衍生物,其制备方法及含有该衍生物的药物组合物作为治疗剂,特别是作为c-Met抑制剂和免疫抑制剂的用途,其中通式(I)的各取代基与说明书中定义相同。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)